Format
Sort by

Send to

Choose Destination

Search results

Items: 19

1.

High definition viral vaccine strain identity and stability testing using full-genome population data--The next generation of vaccine quality control.

Höper D, Freuling CM, Müller T, Hanke D, von Messling V, Duchow K, Beer M, Mettenleiter TC.

Vaccine. 2015 Oct 26;33(43):5829-37. doi: 10.1016/j.vaccine.2015.08.091. Epub 2015 Sep 19.

PMID:
26387431
2.

[Regulatory requirements regarding cell-based medicinal products for human and veterinary use - a comparison].

Kuhlmann-Gottke J, Duchow K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1299-305. doi: 10.1007/s00103-015-2247-x. Review. German.

PMID:
26369765
3.

A new lymphocyte proliferation assay for potency determination of bovine tuberculin PPDs.

Spohr C, Kaufmann E, Battenfeld S, Duchow K, Cussler K, Balks E, Bastian M.

ALTEX. 2015;32(3):201-10. doi: http://dx.doi.org/10.14573/altex.1502101. Epub 2015 May 3.

4.

Colostrum from cows immunized with a vaccine associated with bovine neonatal pancytopenia contains allo-antibodies that cross-react with human MHC-I molecules.

Kasonta R, Holsteg M, Duchow K, Dekker JW, Cussler K, Bendall JG, Bastian M.

PLoS One. 2014 Oct 9;9(10):e109239. doi: 10.1371/journal.pone.0109239. eCollection 2014.

5.

A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.

Krämer B, Kamphuis E, Hanschmann KM, Milne C, Daas A, Duchow K.

Biologicals. 2013 Nov;41(6):400-6. doi: 10.1016/j.biologicals.2013.08.003. Epub 2013 Oct 18.

PMID:
24144483
6.

Effect of the vaccination scheme on PregSure® BVD induced alloreactivity and the incidence of Bovine Neonatal Pancytopenia.

Kasonta R, Sauter-Louis C, Holsteg M, Duchow K, Cussler K, Bastian M.

Vaccine. 2012 Oct 19;30(47):6649-55. doi: 10.1016/j.vaccine.2012.08.069. Epub 2012 Sep 7.

PMID:
22959988
7.

Consistency as an alternative to potency testing.

Duchow K.

Dev Biol (Basel). 2012;134:119-22. No abstract available.

PMID:
22888604
8.

Potency testing of inactivated rabies vaccines using a serological method.

Kamphuis E, Krämer B, Schildger H, Duchow K.

Dev Biol (Basel). 2012;134:23-7.

PMID:
22888591
9.

Vaccination against Feline Panleukopenia: implications from a field study in kittens.

Jakel V, Cussler K, Hanschmann KM, Truyen U, König M, Kamphuis E, Duchow K.

BMC Vet Res. 2012 May 21;8:62. doi: 10.1186/1746-6148-8-62.

10.

Potency testing of veterinary vaccines: the way from in vivo to in vitro.

Romberg J, Lang S, Balks E, Kamphuis E, Duchow K, Loos D, Rau H, Motitschke A, Jungbäck C.

Biologicals. 2012 Jan;40(1):100-6. doi: 10.1016/j.biologicals.2011.10.004. Epub 2011 Nov 9.

PMID:
22075457
11.

Bovine Neonatal Pancytopenia: is this alloimmune syndrome caused by vaccine-induced alloreactive antibodies?

Bastian M, Holsteg M, Hanke-Robinson H, Duchow K, Cussler K.

Vaccine. 2011 Jul 18;29(32):5267-75. doi: 10.1016/j.vaccine.2011.05.012. Epub 2011 May 24.

PMID:
21605614
12.

The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.

Krämer B, Schildger H, Behrensdorf-Nicol HA, Hanschmann KM, Duchow K.

Biologicals. 2009 Apr;37(2):119-26. doi: 10.1016/j.biologicals.2009.01.001. Epub 2009 Jan 31.

PMID:
19181541
13.

Serological responses of adult dogs to revaccination against distemper, parvovirus and rabies.

Ottiger HP, Neimeier-Förster M, Stärk KD, Duchow K, Bruckner L.

Vet Rec. 2006 Jul 1;159(1):7-12.

PMID:
16816154
14.

Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM workshop 48.

Bruckner L, Cussler K, Halder M, Barrat J, Castle P, Duchow K, Gatewood DM, Gibert R, Groen J, Knapp B, Levis R, Milne C, Parker S, Stünkel K, Visser N, Volkers P; ECVAM.

Altern Lab Anim. 2003 Sep;31(4):429-54. No abstract available.

15.

[How to prove complete virus inactivation in rabies vaccines. A comparison of an in vivo to an in vitro method]

Blum SA, Braunschweiger M, Krämer B, Rübmann P, Duchow K, Cubetaler K.

ALTEX. 1998;15(5):46-49.

PMID:
11178540
16.

[Detection of extraneous virus in live vaccines]

Krämer B, Rübmann P, Duchow KC.

ALTEX. 1998;15(5):43-45.

PMID:
11178539
17.

Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia.

Schwanig M, Nagel M, Duchow K, Krämer B.

Vaccine. 1997 Jul;15(10):1047-8. No abstract available.

PMID:
9269045
18.

[Is the abnormal toxicity test still relevant for the safety of vaccines, sera and immunoglobulins?]

Krämer B, Nagel M, Duchow K, Schwanig M, Cussler K.

ALTEX. 1996;13(1):7-16.

PMID:
11178440
19.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk